What if you could finally understand how to use orthobiologics and peptides without crossing regulatory lines? What’s stopping your clinic from offering peptides for healing joints in a legal and efficient way? And how do you actually combine regenerative medicine with real-world protocols for better patient outcomes? In this conversation with Dr. Roddy McGee, I sit down to dissect what clinics need to know right now if they want to successfully adopt orthobiologic therapy, peptides for injur...
All content for The Business of Orthobiologics Podcast is the property of Ariana De Mers and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
What if you could finally understand how to use orthobiologics and peptides without crossing regulatory lines? What’s stopping your clinic from offering peptides for healing joints in a legal and efficient way? And how do you actually combine regenerative medicine with real-world protocols for better patient outcomes? In this conversation with Dr. Roddy McGee, I sit down to dissect what clinics need to know right now if they want to successfully adopt orthobiologic therapy, peptides for injur...
Explore the nuances of leukocyte-rich and leukocyte-poor treatments, and don't forget to consider the role of monocytes. Plus, we'll unravel the mystery of dose calculation and how Patient Reported Outcomes impact registry data. Tune in now to stay ahead in the Orthobiologics game! Follow us and subscribe to our links below ⏬⏬⏬ Website: prp-now.com Apple Podcast: apple.co/3Azvt3R Spotify: spoti.fi/3oICYmh Youtube: bit.ly/drariana
The Business of Orthobiologics Podcast
What if you could finally understand how to use orthobiologics and peptides without crossing regulatory lines? What’s stopping your clinic from offering peptides for healing joints in a legal and efficient way? And how do you actually combine regenerative medicine with real-world protocols for better patient outcomes? In this conversation with Dr. Roddy McGee, I sit down to dissect what clinics need to know right now if they want to successfully adopt orthobiologic therapy, peptides for injur...
